化学化合物与粉样纤维的特定结合的结构机制
Youqi Tao1,2, Wencheng Xia3,4, Qinyue Zhao1,2
1Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Nature chemical biology
|July 3, 2023
概括
了解化合物如何与粉样纤维结合是治疗神经退行性疾病的关键. 这项研究揭示了新的结合机制和α-synuclein纤维的药物可用口袋,使合理的药物设计成为可能.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 神经科学是一个神经科学.
背景情况:
- 粉样纤维素是神经退行性疾病的关键药物点.
- 目前对联结体-纤维素相互作用的理解阻碍了合理的药物设计.
研究的目的:
- 阐明各种化合物与粉样纤维的结合机制.
- 为了确定治疗干预的α-synuclein纤维中的可用药物的口袋.
主要方法:
- 使用冷电子显微镜 (cryo-EM) 可视化复合纤维复合体.
- 一系列的化合物,包括染料和标记剂,被选为结合亲和力.
- 高通量查发现了新的粉样纤维结合剂.
主要成果:
- 低温-EM结构显示出明显的联体纤维结合机制,与规范蛋白相互作用不同.
- 在α-synuclein纤维细胞中发现了一个保存的可用药物的口袋,包括多个系统缩的纤维细胞.
- 几种化合物在α-synuclein纤维结构中显示出明显的密度.
结论:
- 这项研究提供了对粉样纤维细胞状态下的蛋白质-配体相互作用的基本见解.
- 鉴定到的结合机制和囊袋有助于合理设计新的粉样蛋白向治疗方法.
- 这些发现为开发用于神经退行性疾病的有效诊断和治疗药物铺平了道路.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Protein Folding
118.5K
Overview
118.5K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Drug-Receptor Bonds
3.0K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.0K


